Brief Reports
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. May 14, 2005; 11(18): 2822-2826
Published online May 14, 2005. doi: 10.3748/wjg.v11.i18.2822
Table 4 Comparison of the density of proliferation and apoptosis with mild dysplasia in the model-agent group, sulindac-preventative group and sulindac-curative group (number/mm2).
GroupnProliferative cell density(mean±SD)Apoptotic cell density(mean±SD)Ratio (apoptosis/proliferation)
Model-agent588.8±25.746.6±19.1a0.52
Preventtive1388.2±20.765.9±16.30.78
Curative392.3±9.0254.7±11.6a0.78